Today, patients have access to a much wider range of options, including oromucosal sprays, topical products, transdermal patches, and suppositories. Each route has unique advantages and limitations, and understanding these differences can help patients and healthcare providers make more evidence-informed treatment decisions.
‘’Will my colleagues be able to tell?’’ as she anxiously asked. ‘’I’m sorry?’’ I replied with doubt if she’s alluding to the cannabis oil or…
Part 1 of this blog post showed some real-world data from the Santé Cannabis observational study and quickly went over chronic pain classification; next…
Every year we look forward to the International Cannabinoid Research Society (ICRS) Symposium as it brings together world leaders in the field of cannabis research,…
No two cases of Multiple Sclerosis (MS) look the same – the trajectories, outcomes, symptoms and experiences of those living with MS vary from person…
On March 24th, 2021 we were pleased to present our fourth annual medical cannabis forum series, now called the “Conference on cannabinoid-based medicines” – this…
Claims about the therapeutic potential of CBD are ubiquitous online. The World Health Organization among others has confirmed CBD ‘s good safety profile with no…
Millions of people in Canada and around the world have had their lives upended by the ongoing public health crisis. For many, the impact of…